TUS- PHARMACEUTICA financial statements, including revenue, expenses, profit, and loss

The total revenue of 000590 for the last quarter is 75.27 M CNY, and it's 40.98% lower compared to the previous quarter. The net income of Q1 24 is -8.28 M CNY.